Sec Form 3 Filing - Wilderness Trace Veterinary Partners, LLC @ INSPIRE VETERINARY PARTNERS, INC. - 2023-08-29

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 3
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Wilderness Trace Veterinary Partners, LLC
2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
_____ Officer (give title below) X __ Other (specify below)
See Remarks
(Last) (First) (Middle)
780 LYNNHAVEN PARKWAY, SUITE 400
3. Date of Earliest Transaction (MM/DD/YY)
08/29/2023
(Street)
VIRGINIA BEACH, VA23452
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class B Common Stock ( 1 ) ( 2 ) ( 3 ) 2,150,000 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Class B Common Stock ( 1 ) ( 2 ) ( 3 ) ( 3 ) ( 3 ) ( 3 ) Class A Common Stock 2,150,000 I See footnote ( 3 )
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Wilderness Trace Veterinary Partners, LLC
780 LYNNHAVEN PARKWAY
SUITE 400
VIRGINIA BEACH, VA23452
See Remarks
Signatures
/s/ Charles Stith Keiser 09/27/2023
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Shares of Class B common stock are held by Wilderness Trace Veterinary Partners, LLC, which is 100% owned and controlled by Charles Stith Keiser, the issuer's Director and Chief Operating Officer.
( 2 )Following consummation of the initial public offering, Wilderness Trace Veterinary Partners, LLC owns no shares of Class A common stock, approximately 18.7% of all shares of common stock outstanding (Class A and Class B, collectively) and approximately 46.9% of the voting control of the registrant, prior to the conversion or election of any outstanding convertible securities or warrants of the issuer.
( 3 )Each share of Class B common stock is entitled to the same rights applicable to each share of Class A common stock, except each share of Class B common stock is entitled to 25 votes per share of Class B common stock and is convertible at the option of the holder, at any time and from time to time, without the payment of additional consideration, into one share of Class A common stock.

Remarks:
Shares of Class B common stock are held by Wilderness Trace Veterinary Partners, LLC, which is 100% owned and controlled by Charles Stith Keiser, the registrant's Director and Chief Operating Officer

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.